Table 3. Financial Data (2011) .
Costs | BE | ENG | FR | GE | NL | SC | SWE | SWI |
Total healthcare costs as % GDP | 10.5 | 9.4 | 11.6 | 11.3 | 11.9 | 9.4 | 9.5 | 11.0 |
Curative sector as % GDPa | 7.7 | - | 9.1 | 8.6 | 7.4 | - | 7.7 | 8.1 |
Curative sector ($ PPP)a | 2978 | - | 3230 | 3421 | 3171 | - | 3181 | 4155 |
Prescription drugs (% healthcare) | 15.5 | 11.4 | 15.6 | 14.1 | 9.4 | 11.4 | 12.1 | 9.4 |
Per capita prescription drugs (€) | 630 | 374 | 641 | 632 | 479 | 374 | 474 | 530 |
Financing of curative sectorb | ||||||||
% Collective (government, social security) | 71.1 | 82.8 | 76.8 | 77.7 | 78.5c | 82.8 | 80.5 | 64.9 |
% Private (OUPd, private insurance, other) | 28.9 | 17.2 | 23.3 | 22.3 | 21.5c | 17.2 | 19.5 | 35.1 |
% Private OUPd | 25.0 | 9.9 | 9.6 | 11.7 | 11.9c | 9.9 | 19.5 | 25.5 |
Abbreviations: NL, the Netherlands; BE, Belgium; GE, Germany; ENG, England; FR, France; SC, Scotland; SWE, Sweden; SWI, Switzerland; GDP, gross domestic product; PPP, purchasing power parity; OUP, out-of-pocket.
a We defined ‘curative care’ as a combination of the Organization of Economic Cooperation and Development (OECD) health database categories: Services of curative and rehabilitative care, medical goods and ancillary services to healthcare.
b The OECD database did not allow a breakdown in financing for curative care for England and Scotland (both United Kingdom), thus the data represents financing for a broader range of services (including long-term care and public health).
c The data for the Netherlands has been corrected because the deductibles in the OECD data did not impute as private financing.
d Following the OECD definition, out-of-pocket expenditure includes direct payments for care without insurance benefit, co-payments, co-insurance, and deductibles.
Source: OECD health data for 2011.31